V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003855 | 10006521 | null | 76.8 | Palliative (P) | 2017-10-30 | 2017-11-06 | IMATINIB | 2 | N | 10491284 | CHLORAMBUCIL |
| 10003856 | 10002434 | 1.77 | 75.8 | Palliative (P) | 2017-12-25 | 2018-01-04 | FLUOROURACIL | N | N | 10491336 | FLUOROURACIL |
| 10003857 | 10002434 | 1.79 | 80.8 | Palliative (P) | 2017-11-14 | 2017-11-29 | Irinotecan + Modified De Gramont | null | N | 10491336 | IRINOTECAN + MDG |
| 10003858 | 10002435 | null | null | Curative (C) | 2018-10-18 | 2018-10-19 | BCG Intravesical | 02 | N | 10491441 | TEMOZOLOMIDE + RT |
| 10003859 | 10002436 | 1.59 | 0 | Disease modification (D) | null | 2017-06-10 | CISPLATIN + ETOPOSIDE | N | N | 10491449 | CHOP |
| 10003860 | 10006523 | 1.76 | null | Adjuvant (A) | 2018-12-18 | 2018-12-18 | Fluorouracil + Folinic Acid Weekly | N | null | 10491478 | FLUOROURACIL |
| 10003861 | 10002437 | 1.57 | 64 | Adjuvant (A) | 2015-11-08 | 2015-11-22 | Fluorouricil + Folonic Acid (MdG) | N | N | 10491490 | FLUOROURACIL |
| 10003862 | 10006524 | 1.66 | 75.8 | Palliative (P) | 2015-12-19 | 2016-01-08 | FLUOROURACIL | 02 | N | 10491494 | FLUOROURACIL |
| 10003863 | 10002438 | 1.84 | 73 | Curative (C) | null | 2017-09-01 | Paclitaxel 7 day | N | N | 10491528 | BORTEZOMIB |
| 10003864 | 10002439 | 1.74 | 70 | Disease modification (D) | 2016-04-28 | 2016-04-28 | Capecitabine + Cisplatin | 02 | N | 10491551 | EC |
| 10003865 | 10002439 | 1.65 | 66 | Palliative (P) | 2016-12-30 | 2017-01-03 | Temozolomide + RT | N | N | 10491551 | IMATINIB |
| 10003866 | 10002439 | null | null | Adjuvant (A) | null | 2015-10-14 | FEC 100 + DOCETAXEL | null | N | 10491551 | FEC + DOCETAXEL |
| 10003867 | 10002440 | 1.64 | 74 | Palliative (P) | 2017-04-01 | 2017-04-01 | Irinotecan + Modified De Gramont | N | N | 10491751 | IRINOTECAN + MDG |
| 10003868 | 10002441 | null | 87.4 | Palliative (P) | 2013-04-13 | 2013-04-13 | Bortezomib + CYCLOPHOSPHAMIDE | N | null | 10491819 | CAPECITABINE + CISPLATIN |
| 10003869 | 10002441 | 1.84 | 90.9 | Palliative (P) | 2016-12-07 | 2016-12-17 | Chlorambucil | N | N | 10491819 | CTD |
| 10003870 | 10002442 | 1.56 | 61.2 | Curative (C) | 2017-07-18 | 2017-07-28 | Cisplatin + Radiotherapy | 02 | null | 10492185 | CISPLATIN + RT |
| 10003871 | 10002442 | 1.56 | null | Adjuvant (A) | 2016-03-15 | 2016-04-05 | Abiraterone | 2 | Y | 10492185 | PACLITAXEL |
| 10003872 | 10008137 | null | null | Palliative (P) | null | 2018-10-21 | CAPECITABINE + RT | 99 | Y | 10492251 | CAPECITABINE + RT |
| 10003873 | 10008137 | 1.8 | 0 | Disease modification (D) | 2016-10-07 | 2016-10-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10492251 | ABVD |
| 10003874 | 10002443 | 1.61 | 47 | Curative (C) | 2017-12-25 | 2018-01-01 | Azacitidine | 02 | N | 10492449 | EC |
| 10003875 | 10002443 | 0 | 57.9 | Palliative (P) | 2018-03-13 | 2018-04-22 | Abiraterone | 02 | N | 10492449 | CVD |
| 10003876 | 10002444 | 1.75 | 103 | Disease modification (D) | 2015-06-12 | 2015-06-12 | Azacitidine | 02 | Y | 10493337 | ABIRATERONE |
| 10003877 | 10006529 | 1.76 | 87.1 | Curative (C) | 2017-02-15 | 2017-02-21 | Cisplatin + Radiotherapy | N | Y | 10493601 | CISPLATIN + RT |
| 10003878 | 10002445 | 1.66 | 49.3 | Adjuvant (A) | 2017-12-16 | 2017-12-16 | Capecitabine 35days + RT | 02 | Y | 10493788 | CAPECITABINE + RT |
| 10003879 | 10002446 | 1.66 | 67 | Neo-adjuvant (N) | 2017-06-09 | 2017-07-04 | FEC + DOCETAXEL | 02 | null | 10494053 | FEC + DOCETAXEL |
| 10003880 | 10002447 | 1.6 | 95.6 | Curative (C) | 2017-06-10 | 2017-06-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10494098 | CHLORAMBUCIL |
| 10003881 | 10002447 | 1.83 | 82.8 | Disease modification (D) | 2016-08-15 | 2016-08-15 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10494098 | CAPECITABINE + CISPLATIN |
| 10003882 | 10002448 | 1.56 | 50 | Palliative (P) | 2017-11-30 | 2017-11-30 | Cisplatin + Etoposide po&iv 3 day | N | N | 10494436 | CISPLATIN |
| 10003883 | 10002449 | 1.78 | 0 | Palliative (P) | 2017-07-10 | 2017-07-10 | BCG Intravesical | N | N | 10494453 | BORTEZOMIB |
| 10003884 | 10002450 | 1.55 | 61.2 | Palliative (P) | 2016-06-05 | 2016-06-05 | Irinotecan + Modified De Gramont | 02 | N | 10494506 | IRINOTECAN + MDG |
| 10003885 | 10002451 | 1.67 | 79.9 | Adjuvant (A) | 2018-04-20 | 2018-05-16 | CAPECITABINE + GEMCITABINE | 2 | N | 10494641 | IMATINIB |
| 10003886 | 10002452 | 1.82 | 78 | Palliative (P) | 2018-10-23 | 2018-10-23 | EC | 02 | N | 10494722 | TEMOZOLOMIDE + RT |
| 10003887 | 10002453 | 1.68 | 80.8 | Neo-adjuvant (N) | 2018-03-29 | 2018-04-24 | CAPECITABINE + RT | 02 | Y | 10494775 | CAPECITABINE + RT |
| 10003888 | 10002453 | 1.72 | 74.4 | Neo-adjuvant (N) | null | 2014-10-17 | Capecitabine + Cisplatin | N | Y | 10494775 | BORTEZOMIB |
| 10003889 | 10002453 | 1.8 | 80.8 | Disease modification (D) | 2016-09-09 | 2016-09-10 | ABVD | 02 | Y | 10494775 | ABIRATERONE |
| 10003890 | 10002454 | 1.88 | 67.25 | Palliative (P) | 2016-12-12 | 2016-12-16 | IMATINIB | 02 | null | 10495054 | PACLITAXEL |
| 10003891 | 10002455 | 1.6 | 85.4 | Curative (C) | 2018-05-10 | 2018-05-10 | Capecitabine 42days + RT | 02 | Y | 10495244 | CAPECITABINE + RT |
| 10003892 | 10002456 | 1.76 | 78 | Curative (C) | 2018-11-09 | 2018-11-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10495257 | CVD |
| 10003893 | 10002456 | 1.6 | 80.8 | Disease modification (D) | 2017-01-07 | 2017-02-03 | Bortezomib (weekly) | 02 | null | 10495257 | CAPECITABINE + CISPLATIN |
| 10003894 | 10002456 | 1.6 | 64.86 | Disease modification (D) | 2016-02-06 | 2016-02-06 | BCG Intravesical | 02 | N | 10495257 | TEMOZOLOMIDE + RT |
| 10003895 | 10002456 | 1.51 | 76 | Neo-adjuvant (N) | 2017-04-15 | 2017-04-15 | CAPECITABINE + GEMCITABINE | N | null | 10495257 | EC |
| 10003896 | 10002456 | 1.7 | null | Neo-adjuvant (N) | 2015-07-14 | 2015-07-22 | BCG Intravesical | N | N | 10495257 | CAPECITABINE + CISPLATIN |
| 10003897 | 10002456 | null | null | null | 2016-08-07 | 2016-08-07 | Azacitidine | N | Y | 10495257 | CTD |
| 10003898 | 10002457 | null | 95.2 | Neo-adjuvant (N) | 2016-07-23 | 2016-08-13 | Capecitabine 35days + RT | N | Y | 10496079 | CAPECITABINE + RT |
| 10003899 | 10002458 | null | 92.1 | Curative (C) | 2013-09-30 | 2013-10-14 | CISPLATIN + RT | 02 | Y | 10496309 | CISPLATIN + RT |
| 10003900 | 10006533 | 0 | 111.2 | Disease modification (D) | 2017-10-10 | 2017-10-10 | Abiraterone | N | N | 10496431 | EC |
| 10003901 | 10002459 | 1.8 | 75.8 | Adjuvant (A) | 2018-09-18 | 2018-09-26 | Bortezomib +/- Dexamethasone | N | N | 10496480 | BCG |
| 10003902 | 10002459 | 1.57 | 57.9 | null | 2017-12-24 | 2017-12-24 | BCG Intravesical | N | N | 10496480 | ABIRATERONE |
| 10003903 | 10002459 | 1.75 | 62.9 | null | 2014-03-30 | 2014-04-14 | ABVD | 2 | N | 10496480 | PACLITAXEL |
| 10003904 | 10002459 | null | 1.47 | Curative (C) | 2017-07-18 | 2017-07-18 | Azacitidine | N | N | 10496480 | BORTEZOMIB |